Work

Expression of IL-4 in Tumors: A Safety Surrogate to Predict Cancer Survival Associated With Biologic Therapies

Year: 2024

Type: article

Abstract: Interleukin (IL)-4-targeted therapies have revolutionized management of inflammatory dermatoses.

Source: Journal of Drugs in Dermatology

DOI: 10.36849/jdd.7941

Authors: Nikolai Klebanov, Carly Grant, Jeffrey S. Smith, Lourdes M. Perez-Chada, Joseph F Merola

Institutions: Brigham and Women's Hospital, Novartis (Switzerland), Harvard University

Language: English

Topic: Dermatology and Skin Diseases

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4394738179

FWCI:

Cites: 4

Cited by:

Related to: 10